- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Developments in the Use of Antimetabolites
Authors
Keywords
-
Journal
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
Volume 33, Issue 4-6, Pages 358-374
Publisher
Informa UK Limited
Online
2014-06-19
DOI
10.1080/15257770.2014.894197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I study of oral gemcitabine prodrug (LY2334737) in Japanese patients with advanced solid tumors
- (2013) Noboru Yamamoto et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360)
- (2013) Godefridus J. Peters et al. INVESTIGATIONAL NEW DRUGS
- New Challenges and Inspired Answers for Anticancer Drug Discovery and Development
- (2013) T. Utsugi JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity
- (2013) Elizabeth Poplin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours
- (2012) T Doi et al. BRITISH JOURNAL OF CANCER
- Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations
- (2012) Maha Elnaggar et al. CURRENT PHARMACEUTICAL DESIGN
- Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity
- (2012) Won Jun Choi et al. JOURNAL OF MEDICINAL CHEMISTRY
- TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2012) Takayuki Yoshino et al. LANCET ONCOLOGY
- Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors
- (2011) I V Bijnsdorp et al. BRITISH JOURNAL OF CANCER
- A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy
- (2011) S. Pignata et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors
- (2011) Stijn L.W. Koolen et al. CLINICAL CANCER RESEARCH
- Phosphoramidate ProTides of the Anticancer Agent FUDR Successfully Deliver the Preformed Bioactive Monophosphate in Cells and Confer Advantage over the Parent Nucleoside
- (2011) Christopher McGuigan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lipophilic Prodrugs and Formulations of Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
- (2011) Godefridus J. Peters et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells
- (2010) I.V. Bijnsdorp et al. BIOCHEMICAL PHARMACOLOGY
- Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma
- (2010) Raphaël Maréchal et al. CANCER
- Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
- (2010) Andries M. Bergman et al. INVESTIGATIONAL NEW DRUGS
- Mechanism of Inactivation of Human Ribonucleotide Reductase with p53R2 by Gemcitabine 5′-Diphosphate
- (2009) Jun Wang et al. BIOCHEMISTRY
- Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
- (2009) A. Adema et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine
- (2009) David M. Bender et al. JOURNAL OF MEDICINAL CHEMISTRY
- The dual role of thymidine phosphorylase in cancer development and chemotherapy
- (2009) Annelies Bronckaers et al. MEDICINAL RESEARCH REVIEWS
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study
- (2008) S. A. Veltkamp et al. CLINICAL CANCER RESEARCH
- SLC28 genes and concentrative nucleoside transporter (CNT) proteins
- (2008) M. Pastor-Anglada et al. XENOBIOTICA
- Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic?
- (2007) Chris van Bree et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started